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ABSTRACT
Introduction: International clinical guidelines
consistently endorse the promotion of self-
management (SM), including physical activity for
patients with chronic low back pain (CLBP) and
osteoarthritis (OA). Patients frequently receive
individual treatment and advice to self-manage from
physiotherapists in primary care, but the successful
implementation of a clinical and cost-effective group
SM programme is a key priority for health service
managers in Ireland to maximise long-term outcomes
and efficient use of limited and costly resources.
Methods/analysis: This protocol describes an
assessor-blinded cluster randomised controlled
feasibility trial of a group-based education and exercise
intervention underpinned by self-determination theory
designed to support an increase in SM behaviour in
patients with CLBP and OA in primary care
physiotherapy. The primary care clinic will be the unit
of randomisation (cluster), with each clinic randomised
to 1 of 2 groups providing the Self-management of
Osteoarthritis and Low back pain through Activity and
Skills (SOLAS) intervention or usual individual
physiotherapy. Patients are followed up at 6 weeks, 2
and 6 months. The primary outcomes are the (1)
acceptability and demand of the intervention to patients
and physiotherapists, (2) feasibility and optimal study
design/procedures and sample size for a definitive trial.
Secondary outcomes include exploratory analyses of:
point estimates, 95% CIs, change scores and effect
sizes in physical function, pain and disability
outcomes; process of change in target SM behaviours
and selected mediators; and the cost of the
intervention to inform a definitive trial.
Ethics/dissemination: This feasibility trial protocol
was approved by the UCD Human Research Ethics—
Sciences Committee (LS-13-54 Currie-Hurley) and
research access has been granted by the Health
Services Executive Primary Care Research Committee
in January 2014. The study findings will be
disseminated to the research, clinical and health
service communities through publication in peer-
reviewed journals, presentation at national and
international academic and clinical conferences.
Trial registration number: ISRCTN 49875385;
Pre-results.
INTRODUCTION
Chronic musculoskeletal pain conditions are
the leading cause of disability globally,
notably low back pain (LBP) ranked ﬁrst,1
and hip and knee osteoarthritis (OA) ranked
11th in the Global Burden of Disease 2010
study (see online supplementary ﬁle 1).2 The
global point prevalence of LBP was estimated
at 9.4%, with OA hip and knee combined at
3.8%3; Ireland has slightly higher rates of
12% and 4.2%, respectively.4 5 In the over
50s, OA is the leading cause of disability
Strengths and limitations of this study
▪ This protocol describes a cluster randomised
controlled feasibility trial of a theory-driven
group-based intervention for primary care
patients with low back pain and osteoarthritis.
▪ This study will explore the acceptability and
demand of the group-based intervention to
patients and physiotherapists compared with
usual individual physiotherapy.
▪ The exclusion of patients who are unwilling or
unavailable to attend a 6-week group programme
will limit the study’s generalisability.
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worldwide, including Ireland (prevalence rate 12.9%),6
and is predicted to increase due to rising ageing popula-
tions and obesity levels.7 Both conditions place substan-
tial demand on health systems accounting for 10–18% of
consultations in primary care,8 and between 5.4% and
12.6% of total health expenditure.9 In Ireland, 35.5% of
primary care consulters experience chronic non-cancer
pain at a cost of €5.34 billion per year.10 The disability
associated with LBP and OA also places signiﬁcant
burden on families, carers, economies and society
through absenteeism, presenteeism, work disability and
the need for additional social supports.11 12
International clinical practice guidelines consistently
endorse the promotion of self-management (SM) for
people with OA13–15 and chronic LBP16 17 as an integral
component of care, with important elements being edu-
cation about the individual’s chronic condition, its con-
sequences, and its management and the uptake of
evidence-based SM behaviours by participants; including
physical activity, speciﬁc exercise, and pharmacological
and non-pharmacological approaches.15 16
While SM is advocated by policymakers for chronic
health conditions,7 18–20 health service commissioners
require robust evidence of its clinical and cost-
effectiveness prior to widespread implementation.
Recent reviews suggest only small or equivocal effects for
SM compared with other approaches for these condi-
tions,21 22 while group-based SM programmes with
healthcare professional input showed some beneﬁcial
effects, further evidence of their clinical and cost-
effectiveness is needed.23 Within Ireland’s primary care
health system, the majority of patients with OA and
chronic low back pain (CLBP) referred for physiother-
apy (PT) are treated individually24 25 in a diverse range
of health settings by staff with varying degrees of expert-
ise.26 Our recent rapid review found equivocal effective-
ness for individual and group-based SM programmes
with limited cost-effectiveness studies and failed to iden-
tify a group-based intervention for both OA hip/knee
and CLBP.27 These conditions often present concur-
rently in those aged over 45 years,28 29 and could be
treated together in order to maximise outcomes and
minimise inefﬁciencies.30 The successful implementa-
tion of an evidence-based group SM programme for
CLBP and OA is a key priority for Ireland’s PT managers
in current resource constrained times.19
The multifaceted nature of SM interventions with
several interacting components that need to be tailored
to the individual, and underpinned by a collaborative
relationship between the patient and healthcare profes-
sional within the local health service constitutes a
complex intervention,31 notwithstanding the additional
challenges of consistent delivery in a group format,
across a diverse range of health settings with varying
resources and facilities.32 33 It has been argued that the
policy for group interventions to encourage SM in
primary care has raced ahead of the evidence and there
are many unanswered questions for practitioners and
policymakers aiming to establish client groups in terms
of their feasibility, effectiveness and costs.32 33
Therefore, following the Medical Research Council
(MRC) framework,31 34 we developed the
Self-management of OA and LBP through Activity and
Skills (SOLAS) intervention that was acceptable and met
the needs of Ireland’s primary care service stakeholders
and the current evidence which will be reported in
detail in a separate paper. Applying the MRC framework,
it is necessary to establish the feasibility of delivering the
SOLAS intervention to PTs and patients with OA and
CLBP to determine ‘can it work?’, ‘does it work?’ and
‘will it work?’35 in primary care centres in Ireland com-
pared with usual individual PT care, considered the
most appropriate comparison. Hence, a cluster rando-
mised controlled trial (RCT) design was chosen to avoid
contamination of the control group.36 This feasibility
trial will also determine the most efﬁcient and effective
design and sample size for a main effectiveness trial and
provide an estimate of the cost of delivering the inter-
vention compared with usual PT.
Consistent with the recommendations of trial report-
ing guidelines,37 we used theory to guide the design of
the SOLAS intervention, its delivery and the training of
PTs in the feasibility trial. The current lack of theory-
driven interventions in chronic pain populations38–40
may partly explain the poor uptake and continuation of
SM behaviours, such as physical activity, while conversely,
the application of theory to an intervention enables the-
oretically identiﬁed mechanisms of action (ie, media-
tors) to be investigated allowing greater understanding
of how an intervention works and how it can be
enhanced to improve outcomes.41–43 The SOLAS inter-
vention is underpinned by self-determination
theory,44 45 which aims to increase patients’ autonomous
motivation and perceived competence to self-manage
through the needs supportive environment created by
the PT within the group as we have previously demon-
strated in individual PT.25 46 The intervention is also
designed to target speciﬁc determinants of SM behav-
iour (knowledge, skills, self-efﬁcacy/perceived compe-
tence, fear, catastrophising, motivation, behaviour
regulation) in order to increase physical activity and the
use of speciﬁc evidence-based SM behaviours (ie, pain
management using pharmacological and non-
pharmacological approaches, pain coping strategies,
healthy eating for lifestyle and weight management and
speciﬁc exercise) leading to changed health outcomes
as outlined in ﬁgure 1. As the potential for the SOLAS
intervention to result in a change in the target SM beha-
viours is uncertain, the contributing assumptions of this
underlying theoretical model of behaviour change will
be explored within the feasibility trial47 and will further
inform the design of a future effectiveness trial.
Aims and objectives
The aim of this cluster randomised controlled feasibility
trial is to evaluate the feasibility and costs of providing
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the SOLAS intervention (experimental group) to
promote SM for patients with OA hip/knee and/or
CLBP compared with usual PT, which will serve as the
pragmatic control group in order to determine the feasi-
bility of moving to a full scale trial by following the MRC
guidelines.31 48
Our primary objectives are: (1) to assess the accept-
ability and demand of the SOLAS intervention to
patients and physiotherapists compared with usual PT in
order to optimise its design, uptake and delivery; and
(2) to determine the feasibility of trial procedures and
the most efﬁcient and effective study design for a deﬁni-
tive RCT, including its sample size. See table 1 below for
details of feasibility aspects. The secondary objectives
are: (3) to assess medium-term changes in physical func-
tion, pain, emotional and global well-being; (4) to evalu-
ate contributing assumptions of the underlying
theoretical model of behaviour change of the SOLAS
intervention compared with usual PT; and (5) to deter-
mine the costs of the SOLAS intervention compared
with usual PT from the health service and societal
perspectives.
METHODOLOGY
Design and setting
An assessor-blinded multicentre two-arm non-inferiority
cluster randomised controlled feasibility trial (allocation
ratio 1:1) has been designed to assess the methodology
proposed for use in a deﬁnitive RCT. Managers of nine
publicly funded Health Service Executive (HSE) out-
patient primary care PT areas in the greater Dublin,
Ireland, area (population 1.25 million) have agreed to
participate. Centres include 18 HSE primary community
and continuing care clinics (hereafter referred to as
PCCC clinics) with appropriate facilities, equipment and
stafﬁng. A full list of study sites is available from the prin-
cipal investigator (PI). Eligible PTs will be purposively
selected by PT managers based on afﬁliation with suitable
study sites, interest, experience and caseload. Prior to
randomisation, all identiﬁed PTs will receive a PT
participant information leaﬂet, and invitation to provide
written consent to conﬁrm their interest by the project
manager, which will involve completing training (inter-
vention arm) and treatment of patients in the relevant
trial arm. PTs will be invited to contact the project
manager with any questions (see ﬁgure 2) and written
informed consent will be obtained prior to their partici-
pation. PTs will not be blinded to treatment allocation, as
they are implementing the intervention with HSE
patients.
Participants
The following eligibility criteria will be applied to
patients referred for PT to one of the participating
PCCC clinics:
Inclusion: Patients will: have chronic (≥3 months), OA
(National Institute for Health and Care Excellence
(NICE; 2014)15 working diagnosis of OA hip/knee joint:
age 45 years old or over, activity-related joint pain and
no morning joint-related stiffness or morning stiffness
that lasts ≤30 min) and/or LBP (age ≥30 years old and
have non-speciﬁc LBP of mechanical origin with or
without radiation to the lower limb); be able to read/
understand and speak English without assistance; access
to a telephone for screening and available to attend a
6-week group class of 1.5 h/week.
Exclusion: Patients will be excluded if: they have
serious spinal pathology or previous spinal surgery,
nerve root compromise, lower limb arthroplasty, sys-
temic/inﬂammatory or cardiac disease, are scheduled
for major surgery, confounding conditions (neuro-
logical, intellectual or unstable psychiatric condition),
bladder/bowel incontinence, are assessed to be high
risk of falls, had PT in preceding 6 months, are unable/
unwilling to attend or ongoing litigation related to their
pain condition.
Identification, invitation, screening and recruitment
Identifying eligible participants will be a multilevel
process which has been established during the
Figure 1 Process map of behaviour change in SOLAS intervention.
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Table 1 Operational definitions of feasibility aspects related to SOLAS intervention and trial (adapted from Bowen et al)35
Operational definitions
SOLAS intervention Trial procedures
Feasibility Participants Physiotherapists Participants Physiotherapists
Acceptability The extent to which participants
who have received the SOLAS
intervention consider the content,
mode of delivery and support
materials acceptable, appropriate,
and satisfactory in meeting their
needs
The extent to which physiotherapists
who have delivered the SOLAS
intervention consider the training,
content, mode of delivery and support
materials acceptable and appropriate in
meeting their needs and those of their
patients within their service context
The extent to which participants
consider taking part in the trial, and
follow-ups, outcome measure
completion, and fidelity procedures
(direct observation of PTs delivering
intervention) acceptable and
appropriate
The extent to which physiotherapists
who have participated in the trial
consider trial recruitment and fidelity
procedures acceptable and
appropriate
Demand The extent to which participants
adhere to and perceive the burden
of SOLAS intervention weekly class
attendance and target behaviours
The extent to which physiotherapists
perceive the demand and positive/
negative effects of participating in
training, studying intervention
materials, preparing class venue and
delivering the SOLAS intervention,
using specified behaviour change
strategies
The extent to which participants
perceive the burden of participating
in follow-up and completing specific
outcome measures within the trial
The extent to which physiotherapists
perceive the demand of completing
their required tasks for participating in
the trial, including fidelity procedures
(self-report forms)
Implementation The quality and extent to which the
SOLAS intervention will be delivered
as planned by physiotherapists who
have completed training
Practicality The factors influencing the
implementation of the SOLAS
intervention in a range of HSE settings
by a range of physiotherapists taking
into account variations in staffing,
facilities, equipment and class size
Adaptation The extent to which the SOLAS
intervention content, mode of
delivery and support materials will
need to be modified to enhance its
acceptability and implementation for
a future definitive trial
The extent to which the SOLAS
intervention training, programme
content, mode of delivery and support
materials will need to be modified
during/at end of the trial to enhance its
acceptability and implementation for a
future definitive trial
The extent to which trial recruitment,
follow-up and fidelity procedures
and the number and range of
outcome measures will need to be
modified during/at end of the trial to
enhance their acceptability and
implementation for a future definitive
trial
The extent to which trial recruitment
and fidelity procedures, including
physiotherapists tasks, will need to be
modified during/at end of the trial to
enhance acceptability and
implementation for a future definitive
trial
Integration The perceived sustainability and level
of system change that will be needed
to integrate the SOLAS intervention
PT training and programme into
existing HSE community
physiotherapy services
HSE, Health Service Executive; PT, physiotherapy; SOLAS, Self-management of Osteoarthritis and Low back pain through Activity and Skills.
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development phase of this project in agreement with
participating PCCC areas. It will involve the research
team providing referring general practitioners’ (GPs)
with information about the trial, and intervention arms,
PTs raising awareness of the trial at PCCC level,
reviewing waiting lists for suitable referrals and sending
potentially suitable patients an invitation letter, and the
research team undertaking telephone and face-to-face
screening and assessment of consenting participants as
outlined in ﬁgure 2.
Figure 2 Study recruitment, allocation and follow-up (HSE, Health Service Executive; PCCC, primary community and
continuing care; SOLAS, Self-management of Osteoarthritis and Low back pain through Activity and Skills).
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All referrals to participating PCCC clinics will be
reviewed for any potentially eligible patients with hip,
knee or back pain by PTs (age, diagnosis, duration of
symptoms), who will be sent standardised letters inviting
them to contact the research team for information
about the study by phoning (landline or trial mobile),
texting or emailing as preferred. Those who make
contact will be provided with information about the
study, an opportunity to ask questions and if in agree-
ment will be provisionally screened by the researcher
(Chartered PT) via telephone using a standardised ques-
tionnaire (eligibility criteria, Physical Activity Readiness
Questionnaire to conﬁrm medical ﬁtness to participate
in the exercise class49) taking no longer than 10 min.
Interested and potentially eligible patients will be invited
to attend their local PCCC clinic for face-to-face screen-
ing and assessment by the researcher. If indicated the
GP will be contacted after screening or assessment to
conﬁrm the patient is suitable to participate. Patients
will receive a letter containing the participant informa-
tion leaﬂet, study website, conﬁrmation of their appoint-
ment date/time/location, directions and contact details
for queries and a reminder text 24 h in advance. The
researcher will not be blinded to the allocation of each
site but will not inform the patient of their randomisa-
tion allocation until completion of baseline assessment.
A second blinded researcher will review the reasons for
inclusion/exclusion of each patient to conﬁrm lack of
bias of the unblinded researcher.
At the face-to-face assessment, the participant informa-
tion leaﬂet will be reviewed with the researcher and an
opportunity provided to ask questions about the study
and what participation involves, before providing written
informed consent. Consenting participants will then
proceed with screening and assessment, which will
follow a standardised PT subjective and objective assess-
ment for the relevant joint area, and balance testing if
indicated as in other similar trials.50 If eligibility is con-
ﬁrmed, baseline data including the outcome measures
will be completed with support from the researcher, who
will read the questions to each participant unless he/she
prefers to complete independently.
Participants will then be informed of their allocation
by the researcher (based on the random allocation of
PCCC clinic), the aim of the trial will be reiterated, and
an appointment for the start will be provided. The
researcher will notify PTs which patients have given
informed consent and are eligible to participate. All
other patients will be informed of the reason(s) for
ineligiblity (if appropriate), will remain on the waiting
list and advised that they will receive routine PT as soon
as an appointment is available as per usual practice.
Participants will be advised that they are free to withdraw
from treatment and the study at any stage.
Interventions
The interventions are described below in accordance
with current guidelines (SPIRIT,51 TIDieR37 and
Borek52). Participants in both groups will be advised to
continue their normal daily routines and medication,
but will be requested to avoid any other treatment for
their back, hip or knee pain during the study period.
SOLAS intervention
The overarching aim of the SOLAS intervention is to
promote patient SM behaviour, that is, physical activity
and speciﬁc SM strategies, through a group exercise and
education class and accompanying support materials.
See table 2 for details. The intervention is structured
and multicomponent involving (1) education to increase
knowledge about the individual’s chronic condition, its
consequences, and its SM including the role of a healthy
lifestyle and available community resources and (2)
training to impart increased SM behaviours at the end of
the intervention and to enable participants to deploy
these enhanced skills in their lives beyond the interven-
tion. Participants randomised to this arm will receive six
consecutive sessions in a group of up to six participants
led by a PT within a PCCC clinic or nearby community
facility. The overall aim of the programme and the
importance of weekly attendance will be explained
throughout to improve adherence. To support the pro-
motion of participant SM behaviour, its determinants
have been mapped to each session and relevant behav-
iour change techniques incorporated within sessions. In
line with SDT and the importance of social agents in
facilitating autonomous motivation and perceived com-
petence for long-term behaviour change, the PT plays a
crucial role by being needs supportive and enabling par-
ticipants to SM by seeking their input, avoiding control-
ling language such as ‘should’ and ‘must’; and trying to
understand their perspective. The content and dose of
each class (including attendance record, rates and
reasons for non-attendance or early withdrawal of each
participant) will be recorded by the treating therapist in
a weekly treatment record form.
Physiotherapist training in SOLAS intervention rationale,
content and delivery
Prior to implementation, PTs will complete a 2-day (that
is, 12 h) small group training course (up to 8 PTs),
designed and co-facilitated by the intervention develo-
pers; a physiotherapist and senior researcher (DAH) who
holds an MSc in musculoskeletal PT and a PhD in back
pain research, and a registered psychologist and
researcher ( JM) who holds an MA in organisational and
social psychology and a PhD in sport and exercise psych-
ology. The course aims to introduce PTs to the SOLAS
intervention structure, content, support materials and
delivery using a needs supportive interpersonal style.
Training incorporates active participation, collaboration
and experiential learning,54 using multiple learning
methods; brief PowerPoint presentations, videos of ‘good
‘ and ‘poor’ intervention delivery, troubleshooting inter-
vention implementation, and case-based role plays and
microteaching activities to practice intervention delivery.
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Table 2 SOLAS summary intervention map
Session
Self-management behaviours targeted
within the session Intervention content and participant materials
Behaviour change techniques
embedded within sessions (as per
Michie et al)53
1 i. Physical activity
iia. Specific exercise for pain condition
Education: aims of programme, back pain and OA causes, cycle of
change, exercise recommendations, physical activity levels in Ireland,
benefits of exercise/physical activity, review of SOLAS exercise
programme, physical activity diary and goal setting
Exercise: explanation and demonstration of all exercise stations, practice
of sample of exercises
Materials: participant programme handbook
1.1 Goal-setting [behaviour]
1.2 Problem –solving
1.3 Goal-setting (outcome)
1.4 Action planning
1.5 Review behaviour goal
1.6 Discrepancy between current
behaviour and goal
1.7 Review outcome goal
1.8 Behavioural contract
2.2 Feedback on behaviour
2 i. Physical activity
iia. Specific exercise for pain condition
Education: activity rest cycle and pacing activities, use of pedometer,
walking technique, understanding pain, physical activity diary, goal
setting and action plan
Exercise: supervised group exercise class
Materials: Yamax SW-200 Pedometer
2.3 Self-monitoring of behaviour
2.7 Feedback on outcome of behaviour
3.1 Social support [unspecified]
3.2 Social support [practical]
3.3 Social support [emotional]
3 i. Physical activity
iia. Specific exercise for pain condition
iib. Healthy eating for lifestyle and
balanced weight
Education: balanced weight, obesity levels in Ireland, healthy eating,
measuring waist circumference, physical activity diary, goal setting and
action plan, food and drink diary
Exercise: supervised group exercise class
Materials: tape measure, Your Guide to Healthy Eating using the Food
Pyramid, 101+Square Meals cookbook
4.1 Instruction on how to perform the
behaviour
4.2 Information about antecedents of the
behaviour
5.1 Information about health
consequences of the behaviour
5.6 Information about emotional
consequences of the behaviour
6.1 Demonstration of the behaviour
4 i. Physical activity
iia. Specific exercise for pain condition
iic. Use evidence-based pain
management approaches to self-manage
pain condition
Education: mid-way review, evidence-based pain management with ice/
heat, medication, TENS, acupuncture, physical activity diary, goal setting
and action plan
Exercise: supervised group exercise class
6.2 Social comparison
8.1 Behavioural practice/rehearsal
8.6 Generalisation of target behaviour
8.7 Graded tasks
9.1 Credible source
10.4 Social reward
11.1 Pharmacological support
5 i. Physical activity
iia. Specific exercise for pain condition
iid. Use of pain coping strategies
Education: anxiety, mood and pain, managing flare-ups, pain coping
strategies, relaxation techniques and practice, physical activity diary,
goal setting and action plan
Exercise: supervised group exercise class
Relaxation skills: practical group session of contract-relax relaxation
technique led by PT Materials: relaxation CD
11.2 Reduce negative emotions
12.5 Adding objects to the environment
12.6 Body changes
13.2 Framing/Reframing
15.1 Verbal persuasion about capability
Continued
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Each PT will receive precourse materials (ie, intervention
handbook, slides and selected research papers) and fol-
lowing training additional intervention materials and
individualised feedback from one of the course facilita-
tors based on audio recordings during the course.
Usual individual PT
Participants in the control arm will receive usual indivi-
dualised PT management, deﬁned as usual PT treat-
ment in primary care, which is generally in accordance
with international evidence-based guidelines for OA and
CLBP15 55; advice on prescribed exercise, manual
therapy and exercise therapeutic approaches, with
advice and education regarding general lifestyle-related
factors including physical activity and healthy diet less
common.56 The content and dose (frequency and dur-
ation) of treatment provided to each participant will be
at the discretion of the treating PT and explained to par-
ticipants to promote adherence. The rate and reasons
for non-attendance and/or early withdrawal will be
documented by the treating PT in a standardised treat-
ment record form. Recruitment will be from the top of
the waiting list to minimise delay in starting treatment
and to allow comparability at follow-up points with the
experimental arm. PTs will not be permitted to refer
participants to a group-based programme for pain man-
agement during the trial.
Treatment fidelity
A range of quantitative methods (ie, direct observation
and audio recording by researcher, PT self-report) at the
level of treating PTs in both study arms will be used on
at least 20% of the treatment delivery data to assess the
content and quality of treatment ﬁdelity during the trial,
in addition to qualitative interviews with intervention
PTs to assess the feasibility of implementation and its
practicality.57 Fidelity will be assessed and reported by
separate evaluators from the outcome evaluators. The PI
will be the integration point between the ﬁdelity and
outcome evaluation teams.48
Randomisation and blinding
The PCCC clinics will be the unit of randomisation
(cluster) and each clinic will be randomised to the experi-
mental (SOLAS intervention) or control (usual individual
PT) arm on a 1:1 basis. In total, 18 suitable PCCC clinics
initially identiﬁed as suitable for participation were rando-
mised. Following review of geographical proximity of adja-
cent clinics, current availability of PT staff to participate
and withdrawal of clinics, 14 randomised clinics were
agreed with PT managers as available at the start of the
trial. Twelve clinics will proceed with recruitment (six
experimental and six control) and two clinics (one experi-
mental and one control) will be held as contingency in
case recruitment targets are not met. Randomisation will
be conducted using a computerised random number gen-
erator algorithm by a statistician blinded to the purpose of
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Table 3 Feasibility and process of behaviour change outcomes and measures
Variable Measure and items Details
Reliability where
available
Administration
point, trial arms
Expectation of treatment Expectation of treatment
scale58
4-items
Patients and PTs rate how helpful they believe both
individual and group treatment will be for OA and CLBP.
Measured with 10-point numeric rating scales ranging from
not at all helpful to extremely helpful
Internal
consistency: 0.8458
Baseline only
Client satisfaction with outcome
and care
Satisfaction
questionnaire*59
2-items
Patients rate their satisfaction with PT care and their feelings
on hypothetically living the rest of their life with current
symptoms. Measured using 5-point numeric rating scales
Internal
consistency:
0.87–0.9060
2 months, 6 months
Acceptability of treatment and trial
participation
Brief questionnaire
developed for this trial*
11-items
Patients rate their acceptability of treatment received and
trial participation, including the burden of outcome measure
completion. Measured using 5-point numeric rating scales
and yes/no responses
No reliability data
available
6 months
Physical activity International Physical
Activity Questionnaire*61
7-items
Patients provide time spent undertaking vigorous/moderate
physical activity, walking and being sedentary in the last
7 days
Test-retest reliability
range: 0.46–0.9661
Baseline, week 6,
2 months, 6 months
SOLAS self-management
behaviours
Brief questionnaire
developed for this trial*
6-items
Patients describe adherence to target self-management
behaviours in the past week on yes/no and number of day
scales
No reliability data
available
Baseline, week 6,
2 months, 6 months
Pain catastrophising Pain catastrophising
scale62
13-items
Patients indicate their agreement with items following the
question ‘when in pain’ such as I anxiously want the pain to
go away’ on 5-point scales ranging from ‘not at all’ to ‘all of
the time’
Internal
consistency: 0.9563
Baseline, week 6,
2 months, 6 months
Fear Tampa Scale of
Kinesiophobia64
11-items
Patient rate beliefs about their pain on a 4-point scale
ranging from strongly disagree to strongly agree
Internal
consistency: 0.9165
Baseline, week 6,
2 months, 6 months
Self-efficacy Pain Self-Efficacy
Questionnaire66
10-items
Patients rate confidence in performing various activities with
their pain on a 7-point scale ranging from not at all confident
to completely confident
Internal
consistency: 0.9266
Baseline, week 6,
2 months, 6 months
Autonomy support from PT Health Care Climate
Questionnaire67
15-items
Patients rate aspects of their interaction with their PT during
treatment, such as ‘I feel understood by my physiotherapist’
on a 7-point scale ranging from strongly disagree to strongly
agree
Internal
consistency: 0.9667
Week 1, week 6
Autonomous and controlled
motivation (to follow PTs advice
to self-manage)
Treatment
Self-Regulation
Questionnaire68
9-items
Patients rate their agreement with statements on why they
follow their PT’s advice on a 7-point scale ranging from not
true for me to very true for me
Internal
consistency: 0.7668
Baseline, week 6,
2 months, 6 months
Continued
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the study. A researcher will contact all PT managers to
inform them of their allocation arm.
Participant and clinician blinding is not possible due
to the nature of the intervention, and it is also not pos-
sible to blind the researcher at baseline due to the
cluster nature of the study. All follow-up outcome assess-
ments will be conducted by a blinded assessor member
of the research team. The investigators responsible for
data analysis will use a coded data set to ensure blinding.
Semistructured interviews, which include treatment-
speciﬁc questions, will be conducted with intervention
PTs at the end of delivery, and with participants after the
end of outcome measure data collection by unblinded
researchers.
Outcomes and measures
Primary outcomes
The primary outcomes are related to the feasibility of
the SOLAS intervention and trial design and proce-
dures. For participants, this will be assessed by question-
naires (see table 3 below) of treatment expectation,
satisfaction, acceptability and demand of treatment and
trial participation, as well as attendance rates and indi-
vidual qualitative interviews described below. For phy-
siotherapists, a range of feasibility aspects will be
assessed by expectation of treatment questionnaires,
individual and focus group qualitative studies.
Additionally, the feasibility of trial design and proce-
dures will be assessed by piloting the methodological
procedures, monitoring the recruitment and retention
rates and procedures, number and reasons for with-
drawal during the treatment process, feasibility of
outcome measurement, follow-up and ﬁdelity proce-
dures, reﬁning the training programme and calculating
the sample size for a deﬁnitive trial by estimating the
effect sizes and intracluster correlation coefﬁcients of
secondary outcomes.
Secondary measures
At baseline, demographic data including age, gender,
occupational status and clinical presentation will be
documented as well as speciﬁc factors that could inﬂu-
ence the treatment effect; that is, therapists’ personality
(causality orientations), motivation to participate and
treatment expectations; participants’ level of risk of
chronicity (CLBP participants only). The selected sec-
ondary outcome measures are core outcomes for
chronic pain trials including physical functioning, pain
intensity, pain bothersomeness, emotional functioning,
quality of life and global ratings of improvement,72–74 as
well as recommended economic outcomes.75 The
process of change in selected mediators (pain catastro-
phising, fear, self-efﬁcacy/perceived competence and
motivation) and engagement in SM behaviours (physical
activity and speciﬁc SM strategies) will be assessed using
a range of measures. The cost of the SOLAS interven-
tion compared with individual PT will be evaluated using
several resource utilisation and health state measures.
Ta
b
le
3
Co
nt
in
ue
d
V
ar
ia
b
le
M
ea
su
re
an
d
ite
m
s
D
et
ai
ls
R
el
ia
b
ili
ty
w
h
er
e
av
ai
la
b
le
A
d
m
in
is
tr
at
io
n
p
o
in
t,
tr
ia
la
rm
s
A
ut
on
om
ou
s
an
d
co
nt
ro
lle
d
m
ot
iv
at
io
n
(t
o
pa
rt
ic
ip
at
e
in
ph
ys
ic
al
ex
er
ci
se
)
E
xe
rc
is
e
B
eh
av
io
ur
R
eg
ul
at
io
n
Q
ue
st
io
nn
ai
re
6
9
10
-it
em
s
P
at
ie
nt
s
an
sw
er
ite
m
s
re
la
te
d
to
th
ei
r
m
ot
iv
at
io
n
to
en
ga
ge
in
ph
ys
ic
al
ex
er
ci
se
on
a
5-
po
in
t
sc
al
e
ra
ng
in
g
fr
om
no
t
tr
ue
fo
r
m
e
to
ve
ry
tr
ue
fo
r
m
e
In
te
rn
al
co
ns
is
te
nc
y:
0.
89
7
0
B
as
el
in
e,
w
ee
k
6,
2
m
on
th
s,
6
m
on
th
s
P
er
ce
iv
ed
co
m
pe
te
nc
e
(f
or
se
lf-
m
an
ag
em
en
t)
P
er
ce
iv
ed
C
om
pe
te
nc
e
Q
ue
st
io
nn
ai
re
7
1
4-
ite
m
s
P
at
ie
nt
s
ra
te
th
ei
r
pe
rc
ei
ve
d
ab
ili
ty
to
m
an
ag
e
th
ei
r
pa
in
re
gu
la
rly
an
d
in
th
e
lo
ng
te
rm
on
a
7-
po
in
t
sc
al
e
ra
ng
in
g
fr
om
no
t
at
al
lt
ru
e
to
ve
ry
tr
ue
In
te
rn
al
co
ns
is
te
nc
y
ra
ng
e:
0.
80
–
0.
94
7
1
B
as
el
in
e,
w
ee
k
6,
2
m
on
th
s,
6
m
on
th
s
P
er
ce
iv
ed
co
m
pe
te
nc
e
(t
o
en
ga
ge
in
ph
ys
ic
al
ac
tiv
ity
or
ex
er
ci
se
)
P
er
ce
iv
ed
C
om
pe
te
nc
e
Q
ue
st
io
nn
ai
re
7
1
4-
ite
m
s
P
at
ie
nt
s
ra
te
th
ei
r
pe
rc
ei
ve
d
ab
ili
ty
to
ex
er
ci
se
an
d/
or
en
ga
ge
in
ph
ys
ic
al
ac
tiv
ity
re
gu
la
rly
an
d
in
th
e
lo
ng
te
rm
on
a
7-
po
in
t
sc
al
e
ra
ng
in
g
fr
om
no
t
at
al
lt
ru
e
to
ve
ry
tr
ue
In
te
rn
al
co
ns
is
te
nc
y
ra
ng
e:
0.
80
–
0.
94
7
1
B
as
el
in
e,
w
ee
k
6,
2
m
on
th
s,
6
m
on
th
s
*M
in
im
um
da
ta
se
t.
C
LB
P
,
ch
ro
ni
c
lo
w
ba
ck
pa
in
;
O
A
,o
st
eo
ar
th
rit
is
;P
T,
ph
ys
io
th
er
ap
y.
10 Hurley DA, et al. BMJ Open 2016;6:e010728. doi:10.1136/bmjopen-2015-010728
Open Access
group.bmj.com on January 25, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
See table 3 and online supplementary ﬁle 2 for details
of all measures.
Data collection
Secondary outcomes will be collected at baseline, 2 and
6 months from baseline/start of treatment, and there
will be an additional 6-week follow-up time point for col-
lection of process of behaviour change outcomes using
the same data collection methods. This will involve a
face-to-face interview with a researcher at baseline, and
completion at all follow-up points with a blinded
researcher by telephone to minimise participant data
entry errors. The time for completion will be documen-
ted. Participants will receive an information letter and
questionnaire pack 1 week prior to each follow-up point,
and telephone contact to arrange a convenient time for
completion with the researcher. Participants will have
the option to complete outcome assessment by post if
preferred. Non-respondents will be contacted by
phone/text message on three occasions within a 3-day
period to invite completion of outcomes, and if no
response is obtained will be posted the outcome
measure pack (minimum data set) and prepaid enve-
lope, and receive a text reminder inviting completion at
their convenience. All researchers will receive training in
interview skills and outcome measure administration by
the PI prior to the start.
Qualitative studies
Individual qualitative semistructured telephone inter-
views will be conducted with a purposive sample of con-
senting participants who received the SOLAS
intervention or usual PT (2:1 ratio) on completion of
the 6-month follow-up to explore in depth their experi-
ence of treatment and trial participation, necessary
adaptations to optimise acceptability and uptake, and
their use of target SM behaviours. Individual qualitative
semistructured telephone interviews will be conducted
with all PTs following delivery of the SOLAS intervention
to establish their views on the acceptability and demand
of the training course, SOLAS intervention, trial recruit-
ment and ﬁdelity procedures and necessary adaptations
to optimise acceptability and implementation. On com-
pletion of the trial, a focus group with PT managers and
a purposive sample of PTs will assess views on the practi-
cality and potential future integration of the SOLAS
intervention into existing PCCC services to further
inform a deﬁnitive trial.
Sample size
We plan to recruit between 12 and 14 clusters (PCCC
sites) to ensure the intervention is feasible across a
range of settings with variable stafﬁng, facilities, equip-
ment and clientele. There will be a minimum of six clus-
ters in each arm, participating in two waves of
recruitment with the aim to recruit six participants in
each cluster per wave, resulting in 144 participants (72
per arm). Additional clusters (n=2) will only be included
as a contingency if recruitment targets are not met and
added to the ﬁnal study waves. Recommendations for
feasibility studies suggest that the data set for analysis
include at least 30 participants per arm in order to esti-
mate parameters for future sample size calculations.76–78
Accounting for the cluster design effect and assuming
an ICC coefﬁcient of 0.03,79 an effective sample size of
30 would require 36 participants per arm. Allowing for
25% loss to follow-up, we would need to recruit 48 parti-
cipants per arm (96 in total). Therefore, this study size
will be sufﬁciently large to allow a precise estimate of
the ICC coefﬁcient; the greater the number of clusters
the more precise the estimate of the ICC coefﬁcient.80
This study design and sample size should therefore
satisfy the dual aims of (1) feasibility and (2) estimation
of statistics to enable a future sample size calculation for
a deﬁnitive trial.
Data integrity
All hard copy and audio-recorded data will be kept con-
ﬁdential and stored in a locked ﬁling cabinet in the
research group ofﬁce and in softcopy in a password-
protected database only accessible to the PI, data
manager and statistician. The research team will
monitor the integrity of trial data. All participant, group
allocation, treatment record and sociodemographic data
will be coded, and outcome questionnaires scored, and
all data will be double entered into the Statistical
Package for the Social Sciences package to detect and
correct input errors, and range checks will be under-
taken prior to data analysis. A research investigator
unblinded to treatment allocation will perform regular
data checks during data entry and provide feedback to
PTs regarding data omissions where necessary.
Planned analyses
Since this is a feasibility study, extensive exploratory and
descriptive analysis of the data will be undertaken. A
combination of quantitative and qualitative methods will
be used to answer the primary research objectives
related to the feasibility of the intervention and trial pro-
cedures to participants and PTs to determine the feasi-
bility and most efﬁcient and effective study design for a
deﬁnitive trial. Statistical analysis will be by intention to
treat according to participants’ assigned arm of the
study, regardless of whether they attend for treatment or
not. The data analysis plan for treatment ﬁdelity will be
reported separately.
Analysis of the feasibility aspects will be undertaken on
an interim basis after each study wave by the UCD study
team and used to inform minor protocol reﬁnements
for subsequent waves. Qualitative data will be analysed
using inductive thematic analysis, based on Braun and
Clarke’s81 method. Coding frames will be developed
from a review of provisional themes, which will then be
re-examined and reﬁned. The reliability of the identiﬁed
themes will be established by a second researcher who
will independently code a random sample of 25% of
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each data set using the coding frame, with 70% agree-
ment taken as the minimum cut-off rate of agreement.82
The recruitment rate overall, and according to study
arm and PCCC clinic will be calculated in addition to
the ratio of number screened: number enrolled. The
conversion rate and reasons for exclusion/refusal/with-
drawal at each stage in the recruitment process and the
attrition rate during the treatment period will be evalu-
ated. The feasibility of outcome measurement proce-
dures will be assessed by the time to complete measures,
the number of missing items according to outcome
measure, and the follow-up rates and methods of com-
pletion (phone, post) at each time point and partici-
pants’ reported burden of completion.
Analysis of the secondary outcome measure data will
be undertaken at the end of the trial and performed by
the statistician who will remain blinded to group identiﬁ-
cation until analysis is complete. A linear mixed model
will be used to examine change over time in participant
outcomes between treatment groups, while adjusting for
study waves and clinics, and potentially individual PTs.
Treatment effects will be reported with 95% CIs and
ICCs for the clusters. The results will guide a sample size
calculation and the form of the primary analysis for a
deﬁnitive trial. The relationships between the SOLAS
intervention, PT autonomy support and the physical
activity/SM behaviour measures, via potential mediators
(pain catastrophising, fear, self-efﬁcacy/perceived com-
petence and motivation) will be explored, and contin-
gent on adequate sample size, with a series of linear
models,83 and by applying the test of Sobel,84 and struc-
tural equation models, and extended to examine impact
on secondary outcomes. Finally, the cost of the SOLAS
intervention compared with usual PT will be calculated
from the health service and societal perspectives using
data from resource utilisation measures, alongside
exploratory analysis of quality-adjusted life years
(EQ-5D) and disease-speciﬁc measures.85
Adverse effects or events
No adverse events, apart from minor musculoskeletal
complaints in the SOLAS intervention arm due to
unaccustomed exercise, are anticipated. Treatment will
be modiﬁed or discontinued if necessary due to an
increase in symptoms. Participants and PTs will be
informed that any adverse events should be reported
immediately to the PI and will be documented by the
research team by type, length of time and frequency
should they occur.
Trial governance
The Trial Management Committee (TMC), comprising
the PI and local co-investigators, provides overall manage-
ment of the feasibility trial including PCCC clinic set-up,
PT training, recruitment and screening procedures, trial
promotion, data collection, analysis and interpretation.
Trial conduct will be audited on a weekly basis using a
standardised proforma during each recruitment wave,
and biannually at the end of each recruitment wave.
Members of the international scientiﬁc team provide
independent and scientiﬁc oversight of the progress of
the study through the Data Monitoring Committee on
behalf of the funder (Health Research Board).
ETHICS AND DISSEMINATION
All patients and physiotherapists will be provided with
detailed written information and have an opportunity to
discuss participation before providing written consent
and will be advised they can withdraw at any point.
Patients will be invited to give their consent to partici-
pate in a telephone interview following completion of all
follow-ups. The feasibility results will be published in
peer-reviewed journals and presented at national and
international academic, clinical and health service con-
ferences. Any protocol amendments including changes
to eligibility criteria, outcomes or analyses will be com-
municated to the UCD Human Research Ethics—
Sciences Committee and the HSE Primary Care
Research Committee, and noted on the Current
Controlled Trials trial registration page and reported in
the trial results papers.
DISCUSSION
The provision of SM healthcare interventions with
robust evidence of clinical and cost-effectiveness for
chronic conditions, including LBP and OA, are becom-
ing increasingly important due to their rising prevalence
and signiﬁcant impact on the individual, their family
and carers, employers and wider society. The complex
multifaceted nature of supporting patients to engage in
SM behaviours requires an underlying model of behav-
iour change to enhance the likelihood of long-term
adherence and to understand the underlying processes
of change. Group-based interventions that are ﬁrst
designed, adapted and tested for feasibility and cost
implications in partnership with patients’ and healthcare
providers within local health service settings before
robust evaluation in an effectiveness trial have the poten-
tial to address this second translational gap. The feasibil-
ity of the SOLAS theory-driven, group-based complex
intervention will be evaluated from the patient, practi-
tioner and health service manager levels, and if achieved
the trial design will be reﬁned based on the ﬁndings of
this study before moving to a deﬁnitive trial.
Author affiliations
1Institute for Sport and Health and UCD School of Public Health,
Physiotherapy and Sports Science, University College Dublin, Dublin, Ireland
2The George Institute for Global Health, Oxford Martin School, Oxford
University, Oxford, UK
3Breast-Predict—Collaborative Cancer Research Centre, Pharmacology and
Therapeutics, Trinity College Dublin, St James’s Hospital, Dublin, Ireland
4Department of Psychology, University of London, Royal Holloway, London,
UK
5The George Institute for Global Health, Sydney Medical School, University of
Sydney, Sydney, New South Wales, Australia
12 Hurley DA, et al. BMJ Open 2016;6:e010728. doi:10.1136/bmjopen-2015-010728
Open Access
group.bmj.com on January 25, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
6Institute of Nursing and Health Research, Ulster University, Newtownabbey,
UK
7Institute for Positive Psychology and Education, Faculty of Health Sciences,
Australian Catholic University, New South Wales, Australia
8Faculty of Health and Applied Sciences, University of the West of England,
Bristol, UK
9UCD School of Psychology, University College Dublin, Dublin, Ireland
10CSTAR and UCD School of Public Health, Physiotherapy and Sports
Science, University College Dublin, Dublin, Ireland
Acknowledgements The authors wish to thank Collaborators from the SOLAS
Trial team Professor Charles Normand and Dr James F O’Mahony for advice
on the cost analysis, Marian Hernon for contribution to cost methods, and
Alison Keogh and Elaine Toomey for contribution to fidelity methods. The
authors also wish to thank William Fox and Isabelle Jeffares for assistance
with manuscript preparation.
Collaborators Professor Charles Normand, Dr James F O’Mahony,
Marian Hernon, Alison Keogh, Elaine Toomey.
Contributors DAH and AMH conceived the idea for the study and with input
from TP, CM, SMM, SG, CL and SK secured funding. DAH and JM developed
the SOLAS intervention and training programme with input from LC-M, AMH,
SG and NEW. DAH and LC-M designed the trial with input from JM, AMH,
RS, NEW, SG, SMM, CL, SK, CM and TP. RS, DAH and SG devised the
planned analysis. DAH drafted the manuscript with critical input from all
authors.
Funding This article presents independent research funded by the Health
Research Board (Health Research Award 2012/24).
Competing interests None declared.
Ethics approval UCD Human Research Ethics—Sciences Committee, REC
Reference: LS-13-54 Currie-Hurley. Research access: HSE Primary Care
Research Committee.
Provenance and peer review Not commissioned; externally peer reviewed.
Open Access This is an Open Access article distributed in accordance with
the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license,
which permits others to distribute, remix, adapt, build upon this work non-
commercially, and license their derivative works on different terms, provided
the original work is properly cited and the use is non-commercial. See: http://
creativecommons.org/licenses/by-nc/4.0/
REFERENCES
1. Vos T, Barber RM, Bell B, et al. Global, regional, and national
incidence, prevalence, and years lived with disability for 301 acute
and chronic diseases and injuries in 188 countries, 1990–2013: a
systematic analysis for the Global Burden of Disease Study 2013.
Lancet 2015;386:743–800
2. Cross M, Smith E, Hoy D, et al. The global burden of hip and knee
osteoarthritis: estimates from the global burden of disease 2010
study. Ann Rheum Dis 2014;73:1323–30
3. March L, Smith EUR, Hoy DG, et al. Burden of disability due to
musculoskeletal (MSK) disorders. Best Pract Res Clin Rheumatol
2014;28:353–66.
4. Ipsos MRBI Healthy Ireland Survey 2015. Dublin: The Stationery
Office, 2015.
5. Institute of Public Health. Musculoskeletal conditions briefing. Dublin,
2012.
6. French HP, Galvin R, Horgan NF, et al. Prevalence and burden of
osteoarthritis amongst older people in Ireland: findings from the Irish
LongituDinal Study on Ageing (TILDA). Eur J Public Health 2015
[Published Online First: 23 June 2015].
7. Speerin R, Slater H, Li L, et al. Moving from evidence to practice:
models of care for the prevention and management of
musculoskeletal conditions. Best Pract Res Clin Rheumatol
2014;28:479–515.
8. Musculoskeletal Health in Europe Report v5.0 Final. eumusc.net
Driving musculoskeletal health for Europe, Executive Agency for
Health and Consumers.
9. Slobbe L, Kommer G, Smit J, et al. Musculoskeletal Health in
Europe Report v5.0 Final. eumusc.net Driving musculoskeletal
health for Europe, Executive Agency for Health and Consumers.
Costs of illness in the Netherlands 2003. Bilthoven: Rijksinstituut
voor Volksgezondheid en Milieu, 2006.
10. Raftery MN, Ryan P, Normand C, et al. The economic cost of
chronic noncancer pain in Ireland: results from the PRIME study,
part 2. Pain 2012;13:139–45.
11. Wilkie R, Hay EM, Croft P, et al. Exploring how pain leads to
productivity loss in primary care consulters for osteoarthritis:
a prospective cohort study. PLoS ONE 2015;10:e0120042.
12. Buchbinder R, Blyth FM, March LM, et al. Placing the global burden
of low back pain in context. Best Pract Res Clin Rheumatol
2013;27:575–89.
13. Fernandes L, Hagen KB, Bijlsma JW, et al. EULAR
recommendations for the non-pharmacological core management
of hip and knee osteoarthritis. Ann Rheum Dis 2013;72:
1125–35.
14. McAlindon T, Bannuru R, Sullivan M, et al. OARSI guidelines for the
non-surgical management of knee osteoarthritis. Osteoarthritis
Cartilage 2014;22:363–88.
15. Excellence NIFHAC. Osteoarthritis. Care and management in adults.
Clinical Guideline 177. London: NICE, 2014.
16. Delitto A, George SZ, Van Dillen LR, et al. Low back pain. J Orthop
Sports Phys Ther 2012;42:A1–57.
17. Savigny P, Watson P, Underwood M. Early management of
persistent non-specific low back pain: summary of NICE guidance.
BMJ 2009;338:b1805.
18. Health Do. Supporting people with long term conditions: an NHS
and social care model to support local innovation and integration.
Leeds: Department of Health, 2005.
19. HSE. Framework for self-management support, long-term health
conditions: HSE National Advocacy Unit. Secondary framework for
self-management support, long-term health conditions. Dublin: HSE
National Advocacy Unit, 2012.
20. Imison C, Naylor C, Buck D, et al. Transforming our healthcare
system. London: The King’s Fund, 2011.
21. Kroon FP, van der Burg LR, Buchbinder R, et al. Self-management
education programmes for osteoarthritis. Cochrane Database Syst
Rev 2014;1:CD008963.
22. Taylor SJ, Pinnock H, Epiphaniou E, et al. A rapid synthesis of the
evidence on interventions supporting self-management for people
with long-term conditions: PRISMS–practical systematic review of
self-management support for long-term conditions. Southampton:
NIHR Journals Library, 2014.
23. Carnes D, Homer K, Miles C, et al. Effective delivery styles and
content for self-management interventions for chronic
musculoskeletal pain: a systematic literature review. Clin J Pain
2012;28:344–54.
24. French HP, Cusack T, Brennan A, et al. Exercise and manual
physiotherapy arthritis research trial (EMPART) for osteoarthritis of
the hip: a multicenter randomized controlled trial. Arch Phys Med
Rehab 2013;94:302–14.
25. Murray A, Hall A, Williams G, et al. Effect of a self-determination
theory-based communication skills training program on
physiotherapists psychological support for their patients with chronic
low back pain: a randomized controlled trial. Arch Phys Med Rehab
2015;96:809–16.
26. McMahon S, Cusack T, O’Donoghue G. Barriers and facilitators to
providing undergraduate physiotherapy clinical education in the
primary care setting: a three-round Delphi study. Physiotherapy
2014;100:14–19.
27. Toomey EC, Currie-Murphy L, Matthews J, et al. The effectiveness
of physiotherapist-delivered group education and exercise
interventions to promote self-management for people with
osteoarthritis and chronic low back pain: a rapid review part I. Man
Ther 2015;20:365–86. .
28. O’Farrell S, Smart K, Caffrey A, et al. Orthopaedic triage at a
physiotherapist-led ‘Musculoskeletal Assessment Clinic’: a seven-month
service evaluation of outcomes. Ir J Med Sci 2014;183:565–71.
29. Roddy E, Zwierska I, Jordan KP, et al. Musculoskeletal clinical
assessment and treatment services at the primary-secondary care
interface: an observational study. Br J Gen Pract 2013;63:e141–8.
30. Pasquale MK, Dufour R, Joshi AV, et al. Inefficiencies in
osteoarthritis and chronic low back pain management. Am J Manag
Care 2013;19:816–23.
31. Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating
complex interventions: the new Medical Research Council guidance.
BMJ 2008;337:a1655.
32. Greaves CJ, Campbell JL. Supporting self-care in general practice.
Br J Gen Pract 2007;57:814–21.
33. Hoddinott P, Allan K, Avenell A, et al. Group interventions to improve
health outcomes: a framework for their design and delivery. BMC
Public Health 2010;10:800.
Hurley DA, et al. BMJ Open 2016;6:e010728. doi:10.1136/bmjopen-2015-010728 13
Open Access
group.bmj.com on January 25, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
34. Craig P, Petticrew M. Developing and evaluating complex
interventions: reflections on the 2008 MRC guidance. Int J Nurs
Stud 2013;50:585–7.
35. Bowen D, Kreuter M, Spring B, et al. How we design feasibility
studies. Am J Prev Med 2009;36:452–7.
36. Campbell M, Fitzpatrick R, Haines A, et al. Framework for design
and evaluation of complex interventions to improve health. BMJ
2000;321:694–6.
37. Hoffmann TC, Glasziou PP, Boutron I, et al. Better reporting of
interventions: template for intervention description and replication
TIDieR checklist and guide. BMJ 2014;348:g1687.
38. Williams A, Eccleston C, Morley S. Psychological therapies for the
management of chronic pain (excluding headache) in adults.
Cochrane Database Syst Rev 2012;11:CD007407.
39. Keogh A, Tully MA, Matthews J, et al. A review of behaviour change
theories and techniques used in group based self-management
programmes for chronic low back pain and arthritis. Man Ther
2015;20:727–35.
40. Marley J, Tully M, Poter-Armstrong A, et al. A systematic review of
interventions aimed at increasing physical activity in adults with
chronic musculoskeletal pain—protocol. Syst Rev 2014;3:106.
41. Michie S, Abraham C. Identifying techniques that promote health
behaviour change: Evidence based or evidence inspired? Psychol
Health 2004;19:29–49.
42. Rothman AJ. “Is there nothing more practical than a good theory?”:
Why innovations and advances in health behavior change will arise
if interventions are used to test and refine theory. Int J Behav Nutr
Phys Act 2004;1:11.
43. Rothman AJ. Capitalizing on opportunities to refine health behavior
theories. Health Educ Behav 2009;36(5 Suppl):150S–5S; discussion
67S–71S.
44. Ryan D, Deci E. Self-determination theory and the facilitation of
intrinsic motivation, social development and well being. Am Psychol
2000;55:68–78.
45. Ng JY, Ntoumanis N, Thøgersen-Ntoumani C, et al.
Self-determination theory applied to health contexts a meta-analysis.
Perspect Psychol Sci 2012;7:325–40.
46. Matthews J, Hall AM, Hernon M, et al. A brief report on the
development of a theoretically-grounded intervention to promote patient
autonomy and self-management of physiotherapy patients: face validity
and feasibility of implementation. BMC Health Serv Res 2015;15:260.
47. Courneya KS. Efficacy, effectiveness, and behavior change trials in
exercise research. Int J Behav Nutr Phys Act 2010;7:81.
48. Moore GF, Audrey S, Barker M, et al. Process evaluation of complex
interventions: Medical Research Council guidance. BMJ 2015;350:
h1258.
49. Adams R. Revised physical activity readiness questionnaire. Can
Fam Physician 1999;45:1004–5.
50. Walsh N, Cramp F, Palmer S, et al. Exercise and self-management
for people with chronic knee, hip or lower back pain: a cluster
randomised controlled trial of clinical and cost-effectiveness. Study
protocol. Physiotherapy 2013;99:352–7.
51. Chan AW, Tetzlaff JM, Gotzsche PC, et al. SPIRIT 2013 explanation
and elaboration: guidance for protocols of clinical trials. BMJ
2013;346:e7586.
52. Borek AJ, Abraham C, Smith JR, et al. A checklist to improve
reporting of group-based behaviour-change interventions. BMC
Public Health 2015;15:963.
53. Michie S, Richardson M, Johnston M, et al. The behavior change
technique taxonomy (v1) of 93 hierarchically clustered techniques:
building an international consensus for the reporting of behavior
change interventions. Ann Behav Med 2013;46:81–95.
54. Aelterman N, Vansteenkiste M, Keer HV, et al. Development and
evaluation of a training on needs-supportive teaching in physical
education: qualitative and quantitative findings. J Teach Educ
2013;29:64–75.
55. Koes BW, van Tulder M, Lin CW, et al. An updated overview of
clinical guidelines for the management of non-specific low back pain
in primary care. Eur Spine J 2010;19:2075–94.
56. O’Donoghue G, Cunningham C, Murphy F, et al. Assessment and
management of risk factors for the prevention of lifestyle-related
disease: a cross-sectional survey of current activities, barriers and
perceived training needs of primary care physiotherapists in the
Republic of Ireland. Physiotherapy 2014;100:116–22.
57. Borelli B. The assessment, monitoring and enhancement of
treatment fidelity in public health clinical trials. J Public Health Dent
2011;71:S52–63.
58. Smeets RJ, Beelen S, Goossens ME, et al. Treatment expectancy
and credibility are associated with the outcome of both physical and
cognitive-behavioral treatment in chronic low back pain. Clin J Pain
2008;24:305–15.
59. Hurley DA, Tully MA, Lonsdale C, et al. Supervised walking in
comparison with fitness training for chronic back pain in
physiotherapy: results of the SWIFT single-blinded randomized
controlled trial (ISRCTN17592092). Pain 2015;156:131–47.
60. Fischer D, Stewart AL, Bloch DA, et al. Capturing the patient’s
view of change as a clinical outcome measure. JAMA
1999;282:1157–62.
61. Craig CL, Marshall AL, Sjöström M, et al. International physical
activity questionnaire: 12-country reliability and validity. Med Sci
Sports Exerc 2003;35:1381–95.
62. Sullivan MJ, Bishop SR, Pivik J. The pain catastrophizing scale:
development and validation. Psychol Assess 1995;7:524–532.
63. Osman A, Barrios FX, Gutierrez PM, et al. The pain catastrophizing
scale: further psychometric evaluation with adult samples. J Behav
Med 2000;23:351–65.
64. Kori SH, Miller RP, Todd DD. Kinesiophobia: a new view of chronic
pain behavior. Pain Manag 1990;3:35–43.
65. Lundberg MK, Styf J, Carlsson SG. A psychometric evaluation of the
Tampa Scale for Kinesiophobia—from a physiotherapeutic
perspective. Physiother Theory Pract 2004;20:121–33.
66. Nicholas MK. The pain self-efficacy questionnaire: taking pain into
account. Eur J Pain 2007;11:153–63.
67. Williams GC, Freedman ZR, Deci EL. Supporting autonomy to
motivate patients with diabetes for glucose control. Diabetes Care
1998;21:1644–51.
68. Levesque CS, Williams GC, Elliot D, et al. Validating the theoretical
structure of the treatment self-regulation questionnaire (TSRQ) across
three different health behaviors. Health Educ Res 2007;22:691–702.
69. Mullan E, Markland D, Ingledew DK. A graded conceptualisation of
self-determination in the regulation of exercise behaviour:
development of a measure using confirmatory factor analytic
procedures. Pers Individual Differences 1997;23:745–52.
70. Murcia JA, Gimeno EC, Camacho AM. Measuring self-determination
motivation in a physical fitness setting: validation of the Behavioral
Regulation in Exercise Questionnaire-2 (BREQ-2) in a Spanish
sample. J Sports Med Phys Fitness 2007;47:366–74.
71. Williams GC, Deci EL. Internalization of biopsychosocial values by
medical students: a test of self-determination theory. J Pers Soc
Psychol 1996;70:767–79.
72. Chiarotto A, Deyo RA, Terwee CB, et al. Core outcome domains for
clinical trials in non-specific low back pain. Eur J Spine
2015;24:1127–42.
73. Deyo RA, Dworkin SF, Amtmann D, et al. Report of the NIH Task
Force on research standards for chronic low back pain. Pain Med
2014;15:1249–67.
74. Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for
chronic pain clinical trials: IMMPACT recommendations. Pain
2005;113:9–19.
75. HIQA. Guidelines for the economic evaluation of health technologies
in Ireland. 2014. http://www.hiqa.ie/publication/
guidelines-economic-evaluation-healthtechnologiesireland (accessed
27 Nov 2015).
76. Browne RH. On the use of a pilot sample for sample-size
determination. Stat Med 1995;14:1933–40.
77. Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot
studies: recommendations for good practice. J Eval Clin Pract
2004;10:307–12.
78. Shih WJ, Ohman-Strickland PA, Lin Y. Analysis of pilot and early
phase studies with small sample sizes. Stat Med 2004;23:1827–42.
79. Lonsdale C, Hall AM, Williams GC, et al. Communication style and
exercise compliance in physiotherapy (CONNECT). A cluster
randomized controlled trial to test a theory-based intervention to
increase chronic low back pain patients’ adherence to
physiotherapists’ recommendations: study rationale, design, and
methods. BMC Musculoskelet Disord 2012;13:104.
80. Kerry SM, Bland JM. Statistics notes: The intracluster correlation
coefficient in cluster randomisation. BMJ 1998;316:1455–5.
81. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res
Psychol 2006;3:77–101.
82. Guerin S, Hennessy E. Pupils’ definitions of bullying. Eur J Psychol
Educ 2002;17:249–61.
83. Baron RM, Kenny DA. The moderator mediator variable distinction
in social psychological-research—conceptual, strategic, and
statistical considerations. J Pers Soc Psychol 1986;51:
1173–82.
84. Sobel M. Asymptotic confidence intervals for indirect effects
in structural equations models. Sociol Methodol 1982;13:
290–312.
85. Ramsey SD, Willke RJ, Glick H, et al. Cost-effectiveness analysis
alongside clinical trials II-an ISPOR good research practices task
force report. Value Health 2015;18:161–72.
14 Hurley DA, et al. BMJ Open 2016;6:e010728. doi:10.1136/bmjopen-2015-010728
Open Access
group.bmj.com on January 25, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
(SOLAS)
randomised controlled feasibility trial
care physiotherapy: protocol for a cluster 
osteoarthritis and low back pain in primary
intervention to support self-management of 
Theory-driven group-based complex
and SOLAS Trial team
Nicola E Walsh, Suzanne Guerin, Ricardo Segurado, James Matthews
Steve Kamper, Chris Maher, Suzanne M McDonough, Chris Lonsdale, 
Deirdre A Hurley, Amanda M Hall, Laura Currie-Murphy, Tamar Pincus,
doi: 10.1136/bmjopen-2015-010728
2016 6: BMJ Open 
 http://bmjopen.bmj.com/content/6/1/e010728
Updated information and services can be found at: 
These include:
Material
Supplementary
 728.DC1.html
http://bmjopen.bmj.com/content/suppl/2016/01/21/bmjopen-2015-010
Supplementary material can be found at: 
References
 #BIBLhttp://bmjopen.bmj.com/content/6/1/e010728
This article cites 74 articles, 15 of which you can access for free at: 
Open Access
http://creativecommons.org/licenses/by-nc/4.0/non-commercial. See: 
provided the original work is properly cited and the use is
non-commercially, and license their derivative works on different terms, 
permits others to distribute, remix, adapt, build upon this work
Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
This is an Open Access article distributed in accordance with the Creative
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Collections
Topic Articles on similar topics can be found in the following collections 
 (112)Rheumatology
 (360)Research methods
 (166)Rehabilitation medicine
 (418)Qualitative research
 (1357)Public health
 (839)Health services research
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on January 25, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on January 25, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
